San Diego-centered Viking Therapeutics marked itself as a serious competitor while in the weight loss drug industry in February right after revealing promising information from a mid-phase trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when provided to be a weekly injection As well as in Marc